Endomorphins and β-Endorphin Do Not Affect Heart Tolerance to the Pathogenic Effect of Reperfusion


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Selective agonists of μ1- and μ2-opioid receptors endomorphin-2 and endomorphin-1 injected intravenously in a dose of 4500 nmol/kg in 5 min before coronary blood flow resumption had no effect on cardiac reperfusion damage. Consequently, μ1- and μ2-opioid receptors are not involved in the regulation of heart tolerance to reperfusion injury. Nonselective opioid receptor agonist β-endorphin (100 nmol/kg) also did not affect heart tolerance to the pathogenic effect of reperfusion.

About the authors

A. V. Mukhomedzyanov

Research Institute of Cardiology

Email: maslov@cardio-tomsk.ru
Russian Federation, Tomsk

L. N. Maslov

Research Institute of Cardiology

Author for correspondence.
Email: maslov@cardio-tomsk.ru
Russian Federation, Tomsk

S. Yu. Tsibulnikov

Research Institute of Cardiology

Email: maslov@cardio-tomsk.ru
Russian Federation, Tomsk

J. M. Pei

Fourth Military Medical University

Email: maslov@cardio-tomsk.ru
China, Xi’an, Shaanxi Province


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies